15 April 2026 : Clinical Research
Phospho-Histone H3 as a Tool for Improved Mitotic Counting and Risk Assessment in Gastrointestinal Stromal Tumors: A Study of 241 Cases
Xu LiuDOI: 10.12659/MSM.952182
Med Sci Monit 2026; 32:e952182
Table 2 Correlation between MC-PHH3 and MC-HE in GIST with different RS.
| RS | MC-PHH3 | MC-HE | r | P value |
|---|---|---|---|---|
| Very low | 2.00 (2.00, 3.00) | 1.00 (0.00, 3.00) | 0.686 | <0.01 |
| Low | 3.00 (2.00, 4.00) | 3.00 (2.00, 3.00) | 0.644 | <0.01 |
| Medium | 4.00 (3.00, 4.25) | 3.00 (3.00, 4.00) | 0.733 | <0.01 |
| High | 12.50 (4.00, 20.25) | 8.00 (3.00, 15.00) | 0.927 | <0.01 |
| Total | 4.00 (2.50, 8.00) | 3.00 (2.00, 5.00) | 0.879 | <0.01 |
| MC-PHH3 – mitotic count on phospho-histone H3; MC-HE – mitotic count on hematoxylin-eosin; GIST – gastrointestinal stromal tumor; RS – risk stratification. | ||||






